EcoDrugPlus

Beta-1 Adrenergic Receptor-Like

Ensembl ID : ENSNBRG00000017870
Gene Symbol: LOC102789796
3 Cross references
161 Possible Orthologues:

Beta-4c Adrenergic Receptor-Like

Ensembl ID : ENSNBRG00000022047
Gene Symbol: LOC102789844
3 Cross references
196 Possible Orthologues:

Beta-Secretase 1-Like

Ensembl ID : ENSNBRG00000001039
Gene Symbol: LOC102782465
3 Cross references
218 Possible Orthologues:

Bifunctional Epoxide Hydrolase 2-Like

Ensembl ID : ENSNBRG00000020540
Gene Symbol: LOC102789137
3 Cross references
203 Possible Orthologues:

Bile Acid Receptor-Like

Ensembl ID : ENSNBRG00000003805
Gene Symbol: LOC102791128
3 Cross references
387 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSNBRG00000023694
Gene Symbol: BDKRB2
2 Cross references
223 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSNBRG00000023675
Gene Symbol: BDKRB2
3 Cross references
226 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSNBRG00000023677
Gene Symbol: BDKRB2
1 Cross references
220 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSNBRG00000023702
Gene Symbol: BDKRB2
2 Cross references
146 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSNBRG00000023709
Gene Symbol: BDKRB2
4 Cross references
167 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSNBRG00000023687
Gene Symbol: BDKRB2
1 Cross references
222 Possible Orthologues:

Breakpoint Cluster Region Protein-Like

Ensembl ID : ENSNBRG00000010650
Gene Symbol: LOC102793775
3 Cross references
195 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).